Key facts
- AngelEye Health’s last known valuation is $58.0M (Dec 2025).
- It has raised $31.0M across 3 recorded rounds; the latest was Seed Round ($3.0M) in Mar 2025.
- Notable investors include Launch Tennessee, Nationwide Children's Hospital, Arkansas Science & Technology Authority, Bradford Whitmore, Mountain Group Partners — 7 tracked in total.
- AngelEye Health has filed 4 Form Ds with the SEC since 2022, most recently Apr 2025 ($3.0M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for AngelEye Health
Funding rounds
3 roundsAbout AngelEye Health
Developer of a tele-engagement platform designed to allow parents to become part of the care team and be proactive throughout their child's stay in the neonatal intensive care or pediatric unit. The company's platform offers four services that support care team workflows and gives families better access to the treatment plan and progress of their child from any connected device, enabling people to have meaningful care experiences for their families that provide higher satisfaction, improve efficiency, and increase the quality of care.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2013
- Employees
- 39
- Website
- angeleyehealth.com/
- Ownership
- Privately Held (backing)
AngelEye Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AngelEye Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AngelEye Health in its N-PORT filings yet. We sweep new filings monthly.